James Snider
President at Critical Care Diagnostics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dennis Dalangin | M | - |
Critical Care Diagnostics, Inc.
 Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | 12 years |
| David M. Geliebter | M | - |
Critical Care Diagnostics, Inc.
Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | 20 years |
| Sven M. Jacobson | M | - |
Critical Care Diagnostics, Inc.
Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | 20 years |
| Sari Rapkin | F | - |
Jcc Greater Boston
| - |
| Lily Rabinoff-Goldman | M | - |
Jcc Greater Boston
| - |
| Mark Barrocas | M | 52 |
Jcc Greater Boston
| - |
| Rebecca Diamondstein | F | - |
Jcc Greater Boston
| - |
| Eliav Kahan | M | - |
Jcc Greater Boston
| - |
| Bill Heitin | M | - |
Jcc Greater Boston
| - |
| Tamar Frieze | M | - |
Jcc Greater Boston
| - |
| Jennifer Cramer | F | - |
Jcc Greater Boston
| - |
| Avi Almozlino | M | - |
Jcc Greater Boston
| - |
| Richard Scherr | M | - |
Jcc Greater Boston
| - |
| Ginny MacDowell | F | - |
Jcc Greater Boston
| - |
| Allison Hirsch | F | - |
Jcc Greater Boston
| - |
| Betsy Hecker | F | - |
Jcc Greater Boston
| - |
| Felice Friedman | F | - |
Jcc Greater Boston
| - |
| Mara Goldstein | F | - |
Jcc Greater Boston
| - |
| Andrew Lamson | M | - |
Jcc Greater Boston
| - |
| David Shimoni | M | - |
Jcc Greater Boston
| - |
| Steven Bearak | M | - |
Jcc Greater Boston
| - |
| David Begelfer | M | - |
Jcc Greater Boston
| - |
| Mitchell Leiman | M | - |
Jcc Greater Boston
| - |
| Greg Cerra | M | - |
Critical Care Diagnostics, Inc.
Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | 9 years |
| Ari Sussman | M | - |
Jcc Greater Boston
| - |
| Avi Liss | M | 44 |
Jcc Greater Boston
| - |
| Andrew Blidy | M | - |
Critical Care Diagnostics, Inc.
Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | 12 years |
| Jennifer Aronson | F | - |
Jcc Greater Boston
| - |
| Joel Samen | M | - |
Jcc Greater Boston
| - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 29 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- James Snider
- Personal Network
